ACTIVE

Biomedical Alliance in Europe

Export PDF

Financial year 2017 · Closed on 31/12/2017

Net result11,1 k €+129,6 %over 1 year
Gross margin82,4 k €+150,9 %over 1 year
Equity238,5 k €+4,9 %over 1 year
Workforce1,0 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

Biomedical Alliance in Europe is a Non-profit organization incorporated in 2010. Its main activity is: Activities of professional membership organisations. Its registered office is in Bruxelles. It employs on average 1,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0831.609.704
Incorporation
03/12/2010
Legal form
Non-profit organization
Registered office
Rue de la Loi 34/36
1000 Bruxelles · BruxellesSee on map
Latest accounts
31/12/2017
Average workforce
1,0 ETP
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 5 filings

Trend over 5 financial years

20172016201520142013
Income statement
Gross margin82,4 k €32,8 k €93,2 k €75,7 k €48,5 k €
EBITDA11,2 k €-37,5 k €17,8 k €62,5 k €47,9 k €
Operating result11,2 k €-37,5 k €17,8 k €62,5 k €47,9 k €
Net result11,1 k €-37,4 k €18,1 k €62,5 k €47,9 k €
Balance sheet
Equity238,5 k €227,4 k €264,8 k €246,8 k €184,3 k €
Total assets252,2 k €240,6 k €279,2 k €251,6 k €184,6 k €
Cash252,2 k €240,6 k €278,3 k €251,6 k €184,6 k €
Debts13,7 k €13,2 k €14,4 k €4,8 k €314 €
Other
Workforce1,0 ETP1,0 ETP1,0 ETP1,0 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2017

3 active · 11 ended

Active mandates

Colm Prof. O'Morain

Chairman of the board of directors · since 01 janvier 2016 · until 31 décembre 2017

Active
Steffen Prof. Gay

Director · since 01 janvier 2016 · until 31 décembre 2017

Active
Wilfried Prof. Elmeier

Director · since 01 janvier 2016 · until 31 décembre 2017

Active

Ended mandates

European Association for the Study of Diabetes

Director

Represented by Ulf Prof. SMITH

Ended
European Association for the Study of diabetes (EASD)

Director

Represented by Ulf SMITH

Ended
European Association for the Study of Diabetes (EASD)

Director

Represented by Ulf SMITH

Ended
European Cancer Organisation

Director · 0450.934.093

Represented by Caroline Prof. DIVE

Ended

Full financial information

Source · NBB
20172016201520142013
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/201701/01/201601/01/201501/01/201401/01/2013
Closing of the financial year31/12/201731/12/201631/12/201531/12/201431/12/2013
Length of the financial year12 months12 months12 months12 months12 months
Filing date19/09/201830/06/201717/11/201614/09/201531/12/2014
General meeting25/04/201826/04/201709/11/201611/05/201513/10/2014
Currency of the financial yearEUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/201725/04/201819/09/2018FrenchPDF
Abridged model31/12/201626/04/201730/06/2017FrenchPDF
Abridged model31/12/201509/11/201617/11/2016FrenchPDF
Abridged model31/12/201411/05/201514/09/2015FrenchPDF
Abridged model31/12/201313/10/201431/12/2014FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2017

3 active · 11 ended

Active mandates

Colm Prof. O'Morain

Chairman of the board of directors · since 01 janvier 2016 · until 31 décembre 2017

Active
Steffen Prof. Gay

Director · since 01 janvier 2016 · until 31 décembre 2017

Active
Wilfried Prof. Elmeier

Director · since 01 janvier 2016 · until 31 décembre 2017

Active

Ended mandates

European Association for the Study of Diabetes

Director

Represented by Ulf Prof. SMITH

Ended
European Association for the Study of diabetes (EASD)

Director

Represented by Ulf SMITH

Ended
European Association for the Study of Diabetes (EASD)

Director

Represented by Ulf SMITH

Ended
European Cancer Organisation

Director · 0450.934.093

Represented by Caroline Prof. DIVE

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates13/03/2025
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates17/06/2024
    SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates03/02/2022
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates25/01/2019
    DENOMINATION - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates09/08/2017
    DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Other14/12/2010
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2017
    Annual accounts 201711,1 k €↑
  2. 2017
    Name changeBiomedical Alliance in Europe
  3. 2016
    Annual accounts 2016-37,4 k €↓
  4. 2015
    Annual accounts 201518,1 k €↓
  5. 2014
    Annual accounts 201462,5 k €↑
  6. 2013
    Annual accounts 201347,9 k €
  7. 2013
    Name changeAlliance for Biomedical Research in Europe
  8. 03/12/2010
    IncorporationNon-profit organization